Mutual fund · AMFI 154547
Invesco India Pharma and Healthcare Fund
NAV ₹10.60 · 17 Nov 2026
Invesco India Pharma and Healthcare Fund is a sectoral fund mutual fund run by . Its NAV was ₹10.60 on 17 Nov 2026. The direct plan's total expense ratio was 1.9% in the latest AMFI data. The top 10 holdings made up 78.1% of the portfolio in October 2026.
Returns from NAV
One year and shorter are absolute; three and five years are annualised. Based on NAV, so dividend payouts are not added back. Past performance does not guarantee future results.
What the fund charges
From AMFI's expense ratio data, updated 19 Nov 2026. The regular plan charges more; see the fund's factsheet.
Portfolio · October 2026
Top holdings (15 in total)
| Company | % of fund | vs last month |
|---|---|---|
| Apollo Hospitals Enterprise Limited | +1.05 | |
| Divi's Laboratories Limited | +0.89 | |
| Max Healthcare Institute Limited | -0.99 | |
| Sai Life Sciences Limited | -0.14 | |
| Sun Pharmaceutical Industries Limited | -0.68 | |
| Manipal Health Enterprises Ltd | -0.01 | |
| Dr Agarwals Health Care Limited | +1.61 | |
| Sahajanand Medical Technologies Limited | new | |
| Global Health Limited | -1.04 | |
| Corona Remedies Limited | -0.37 | |
| Glenmark Pharmaceuticals Limited | -0.38 | |
| Torrent Pharmaceuticals Limited | -0.51 | |
| Krishna Institute Of Medical Sciences Limited | -0.34 | |
| Aster DM Quality Care Limited | +1.6 | |
| Mankind Pharma Limited | new |
The top 10 make up 78.1% of the fund. Source: the fund house's monthly portfolio disclosure.
Since September 2026
What changed
New holdings
- Sahajanand Medical Technologies Limited7.31%
- Mankind Pharma Limited2.03%
Biggest changes in weight
- Dr Agarwals Health Care Limited6.32% to 7.93%
- Aster DM Quality Care Limited1.99% to 3.59%
- Apollo Hospitals Enterprise Limited8.03% to 9.08%
- Global Health Limited7.0% to 5.96%
By sector
Where the money is
Healthcare Services47.5%
Pharmaceuticals & Biotechnology42.2%
Healthcare Equipment & Supplies7.3%
Learn more
Mutual fund guides
Your mutual funds
Review your own mutual fund portfolio
Upload or fetch your holdings and see each fund's returns, cost and overlap against benchmarks, as facts. Review my mutual funds
Questions
About Invesco India Pharma and Healthcare Fund
What is the NAV of Invesco India Pharma and Healthcare Fund?
The net asset value was Rs 10.60 on 17 November 2026.
What is the expense ratio of Invesco India Pharma and Healthcare Fund?
The direct plan's total expense ratio was 1.9% in the latest AMFI data, about Rs 19,000 a year on Rs 10 lakh invested.
What is the one-year return of Invesco India Pharma and Healthcare Fund?
The fund does not have a full year of NAVs yet.
Data: AMFI NAVs and expense ratios and the fund house's monthly portfolio disclosures. This page states facts and is not a recommendation to buy or sell. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future results.